215 related articles for article (PubMed ID: 6154662)
41. Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells.
Pattengale PK; Gidlund M; Nilsson K; Sundström C; Sällström J; Simonsson B; Wigzell H
Int J Cancer; 1982 Jan; 29(1):1-7. PubMed ID: 6174459
[TBL] [Abstract][Full Text] [Related]
42. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
43. Intraperitoneal administration of Corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: effects on cytotoxicity of tumor-associated macrophages and NK cells.
Mantovani A; Sessa C; Peri G; Allavena P; Introna M; Polentarutti N; Mangioni C
Int J Cancer; 1981; 27(4):437-46. PubMed ID: 6168590
[No Abstract] [Full Text] [Related]
44. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
[TBL] [Abstract][Full Text] [Related]
45. Mechanism of K562-induced human natural killer cell inactivation using highly enriched effector cells isolated via a new single-step sheep erythrocyte rosette assay.
Abrams SI; Brahmi Z
Ann Inst Pasteur Immunol; 1988; 139(4):361-81. PubMed ID: 3166753
[TBL] [Abstract][Full Text] [Related]
46. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM
J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594
[TBL] [Abstract][Full Text] [Related]
47. Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities.
Fukui H; Overton WR; Herberman RB; Reynolds CW
J Leukoc Biol; 1987 Feb; 41(2):130-42. PubMed ID: 2433376
[TBL] [Abstract][Full Text] [Related]
48. The sensitivity of placental trophoblast cells to intraplacental and allogeneic cytotoxic lymphocytes.
Pross H; Mitchell H; Werkmeister J
Am J Reprod Immunol Microbiol; 1985 May; 8(1):1-9. PubMed ID: 4014527
[TBL] [Abstract][Full Text] [Related]
49. Measurement of NK activity in effector cells purified from canine peripheral lymphocytes.
Knapp DW; Leibnitz RR; DeNicola DB; Turek JJ; Teclaw R; Shaffer L; Chan TC
Vet Immunol Immunopathol; 1993 Jan; 35(3-4):239-51. PubMed ID: 8430495
[TBL] [Abstract][Full Text] [Related]
50. Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.
Patankar MS; Jing Y; Morrison JC; Belisle JA; Lattanzio FA; Deng Y; Wong NK; Morris HR; Dell A; Clark GF
Gynecol Oncol; 2005 Dec; 99(3):704-13. PubMed ID: 16126266
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of human natural cell-mediated cytotoxicity by interferon.
Moore M; Potter MR
Br J Cancer; 1980 Mar; 41(3):378-87. PubMed ID: 6155926
[TBL] [Abstract][Full Text] [Related]
52. Cytotoxicity against the K562 erythroleukemia cell line by human natural killer (NK) cells which do not bear free Fc receptors for IgG.
Kay HD; Fagnani R; Bonnard GD
Int J Cancer; 1979 Aug; 24(2):141-50. PubMed ID: 290570
[TBL] [Abstract][Full Text] [Related]
53. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
54. Depletion of NK by cellular immunoadsorption.
Jensen PJ; Koren HS
J Immunol; 1979 Sep; 123(3):1127-32. PubMed ID: 89160
[TBL] [Abstract][Full Text] [Related]
55. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
56. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.
Allavena P; Peccatori F; Maggioni D; Erroi A; Sironi M; Colombo N; Lissoni A; Galazka A; Meiers W; Mangioni C
Cancer Res; 1990 Nov; 50(22):7318-23. PubMed ID: 2121337
[TBL] [Abstract][Full Text] [Related]
57. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
Strauss G; Gückel B; Wallwiener D; Moldenhauer G
Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
[TBL] [Abstract][Full Text] [Related]
58. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
59. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
60. Natural killer activity and low-affinity E rosettes in acute leukemias.
Matera L; Giancotti FG
Acta Haematol; 1983; 70(3):158-62. PubMed ID: 6410642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
